Saniya Tandon, Salma Ayis, David Hopkins, Seeromanie Harding, Marietta Stadler. Diabetes Obes Metab 2021
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora. Diabetes Ther 2020
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora. Diabetes Ther 2020
100
Ranking treatments in frequentist network meta-analysis works without resampling methods.
Gerta Rücker, Guido Schwarzer. BMC Med Res Methodol 2015
Gerta Rücker, Guido Schwarzer. BMC Med Res Methodol 2015
100
GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?
Michael A Nauck, Juris J Meier. Lancet Diabetes Endocrinol 2020
Michael A Nauck, Juris J Meier. Lancet Diabetes Endocrinol 2020
100
NICE guidance on sotagliflozin for type 1 diabetes.
Amanda I Adler, Jessica Cronshaw, Carl Prescott, Sanjeev Patel, Eleanor Donegan, Jasdeep Hayre. Lancet Diabetes Endocrinol 2020
Amanda I Adler, Jessica Cronshaw, Carl Prescott, Sanjeev Patel, Eleanor Donegan, Jasdeep Hayre. Lancet Diabetes Endocrinol 2020
100
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta. BMJ 2019
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta. BMJ 2019
100
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
100
CINeMA: An approach for assessing confidence in the results of a network meta-analysis.
Adriani Nikolakopoulou, Julian P T Higgins, Theodoros Papakonstantinou, Anna Chaimani, Cinzia Del Giovane, Matthias Egger, Georgia Salanti. PLoS Med 2020
Adriani Nikolakopoulou, Julian P T Higgins, Theodoros Papakonstantinou, Anna Chaimani, Cinzia Del Giovane, Matthias Egger, Georgia Salanti. PLoS Med 2020
100
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
100
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
100
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
100
Systematic literature review and network meta-analysis of sodium-glucose co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes.
Bryony E Langford, Marc Evans, Tao Haskins-Coulter, Molly O'Connor, Harriet E O Cant, Lucy A Eddowes, Christopher Edmonds, Amarjeet Tank. Diabetes Obes Metab 2020
Bryony E Langford, Marc Evans, Tao Haskins-Coulter, Molly O'Connor, Harriet E O Cant, Lucy A Eddowes, Christopher Edmonds, Amarjeet Tank. Diabetes Obes Metab 2020
100
Checking consistency in mixed treatment comparison meta-analysis.
S Dias, N J Welton, D M Caldwell, A E Ades. Stat Med 2010
S Dias, N J Welton, D M Caldwell, A E Ades. Stat Med 2010
100
Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions.
Anna Chaimani, Georgia Salanti. Res Synth Methods 2012
Anna Chaimani, Georgia Salanti. Res Synth Methods 2012
100
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes.
Dominic Ehrmann, Bernhard Kulzer, Timm Roos, Thomas Haak, Mohammed Al-Khatib, Norbert Hermanns. Lancet Diabetes Endocrinol 2020
Dominic Ehrmann, Bernhard Kulzer, Timm Roos, Thomas Haak, Mohammed Al-Khatib, Norbert Hermanns. Lancet Diabetes Endocrinol 2020
100
Incretin-based therapies for patients with type 1 diabetes: a meta-analysis.
Lili Liu, Zhuo Shao, Ying Xia, Jiabi Qin, Yang Xiao, Zhiguang Zhou, Zubing Mei. Endocr Connect 2019
Lili Liu, Zhuo Shao, Ying Xia, Jiabi Qin, Yang Xiao, Zhiguang Zhou, Zubing Mei. Endocr Connect 2019
100
Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials.
Jingli Lu, Lijuan Tang, Haiyang Meng, Junjie Zhao, Yan Liang. Diabetes Metab Res Rev 2019
Jingli Lu, Lijuan Tang, Haiyang Meng, Junjie Zhao, Yan Liang. Diabetes Metab Res Rev 2019
100
Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool.
Georgia Salanti. Res Synth Methods 2012
Georgia Salanti. Res Synth Methods 2012
100
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.
Rebecca M Turner, Jonathan Davey, Mike J Clarke, Simon G Thompson, Julian Pt Higgins. Int J Epidemiol 2012
Rebecca M Turner, Jonathan Davey, Mike J Clarke, Simon G Thompson, Julian Pt Higgins. Int J Epidemiol 2012
100
NICE guidance on dapagliflozin with insulin for type 1 diabetes.
Amanda I Adler, Sharlene Ting, Ross Dent, Nick Latimer. Lancet Diabetes Endocrinol 2019
Amanda I Adler, Sharlene Ting, Ross Dent, Nick Latimer. Lancet Diabetes Endocrinol 2019
100
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
100
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
100
Meta-analyses involving cross-over trials: methodological issues.
Diana R Elbourne, Douglas G Altman, Julian P T Higgins, Francois Curtin, Helen V Worthington, Andy Vail. Int J Epidemiol 2002
Diana R Elbourne, Douglas G Altman, Julian P T Higgins, Francois Curtin, Helen V Worthington, Andy Vail. Int J Epidemiol 2002
100
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.
J P T Higgins, D Jackson, J K Barrett, G Lu, A E Ades, I R White. Res Synth Methods 2012
J P T Higgins, D Jackson, J K Barrett, G Lu, A E Ades, I R White. Res Synth Methods 2012
100
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
100
The number needed to treat in pairwise and network meta-analysis and its graphical representation.
Areti Angeliki Veroniki, Ralf Bender, Paul Glasziou, Sharon E Straus, Andrea C Tricco. J Clin Epidemiol 2019
Areti Angeliki Veroniki, Ralf Bender, Paul Glasziou, Sharon E Straus, Andrea C Tricco. J Clin Epidemiol 2019
100
Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data.
Kirsty M Rhodes, Rebecca M Turner, Julian P T Higgins. J Clin Epidemiol 2015
Kirsty M Rhodes, Rebecca M Turner, Julian P T Higgins. J Clin Epidemiol 2015
100
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
100
Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study.
B Nussbaumer-Streit, I Klerings, A I Dobrescu, E Persad, A Stevens, C Garritty, C Kamel, L Affengruber, V J King, G Gartlehner. J Clin Epidemiol 2020
B Nussbaumer-Streit, I Klerings, A I Dobrescu, E Persad, A Stevens, C Garritty, C Kamel, L Affengruber, V J King, G Gartlehner. J Clin Epidemiol 2020
100
100
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
100
Model-Based Network Meta-Analysis: A Framework for Evidence Synthesis of Clinical Trial Data.
D Mawdsley, M Bennetts, S Dias, M Boucher, N J Welton. CPT Pharmacometrics Syst Pharmacol 2016
D Mawdsley, M Bennetts, S Dias, M Boucher, N J Welton. CPT Pharmacometrics Syst Pharmacol 2016
100
A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses.
Alan Maloney, Julio Rosenstock, Vivian Fonseca. Clin Pharmacol Ther 2019
Alan Maloney, Julio Rosenstock, Vivian Fonseca. Clin Pharmacol Ther 2019
100
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
100
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.